Published: 2022-09-22 21:46:29.236732Category:ScienceType:IllustrationModel release: No
Share
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody for the treatment of osteoporosis.